PL2084132T3 - Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry - Google Patents

Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry

Info

Publication number
PL2084132T3
PL2084132T3 PL06795893T PL06795893T PL2084132T3 PL 2084132 T3 PL2084132 T3 PL 2084132T3 PL 06795893 T PL06795893 T PL 06795893T PL 06795893 T PL06795893 T PL 06795893T PL 2084132 T3 PL2084132 T3 PL 2084132T3
Authority
PL
Poland
Prior art keywords
positively charged
skin penetration
penetration rate
charged water
soluble prodrugs
Prior art date
Application number
PL06795893T
Other languages
English (en)
Inventor
Chongxi Yu
Lina Xu
Original Assignee
Techfields Biochem Co. Ltd
Chongxi Yu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Techfields Biochem Co. Ltd, Chongxi Yu filed Critical Techfields Biochem Co. Ltd
Publication of PL2084132T3 publication Critical patent/PL2084132T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/30Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL06795893T 2006-09-03 2006-09-03 Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry PL2084132T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06795893.4A EP2084132B1 (en) 2006-09-03 2006-09-03 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
PCT/IB2006/053090 WO2008029199A1 (en) 2006-09-03 2006-09-03 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate

Publications (1)

Publication Number Publication Date
PL2084132T3 true PL2084132T3 (pl) 2019-03-29

Family

ID=39156867

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06795893T PL2084132T3 (pl) 2006-09-03 2006-09-03 Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry
PL13153470T PL2623495T3 (pl) 2006-09-03 2006-09-03 Dodatnio naładowane rozpuszczalne w wodzie proleki kwasów n-aryloantranilowych o bardzo dużej szybkości przenikania przez skórę

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL13153470T PL2623495T3 (pl) 2006-09-03 2006-09-03 Dodatnio naładowane rozpuszczalne w wodzie proleki kwasów n-aryloantranilowych o bardzo dużej szybkości przenikania przez skórę

Country Status (5)

Country Link
EP (2) EP2084132B1 (pl)
CN (1) CN101506168B (pl)
ES (2) ES2735287T3 (pl)
PL (2) PL2084132T3 (pl)
WO (1) WO2008029199A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632866B2 (en) 2002-10-21 2009-12-15 Ramot At Tel Aviv University Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
WO2008041054A1 (en) 2006-10-02 2008-04-10 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
AU2006350707A1 (en) 2006-11-08 2008-05-15 Chongxi Yu Transdermal delivery systems of peptides and related compounds
CA2671938C (en) 2006-12-10 2017-10-17 Chongxi Yu Transdermal delivery systems of beta-lactam antibiotics
DK2125697T3 (en) 2007-01-15 2016-11-14 Chongxi Yu POSITIVELY CHARGED WATER-SOLUBLE PRODRUGS OF RETINOIDS AND RETINOID SIMILAR COMPOUNDS WITH VERY HIGH SKIN PENETRATION
PL2115140T3 (pl) 2007-01-31 2017-03-31 Yu Dodatnio naładowane rozpuszczalne w wodzie proleki 1H-imidazo[4,5-c]chinolino-4-amin i powiązane związki o bardzo wysokich wskaźnikach penetracji przez skórę
KR20210103586A (ko) * 2007-06-04 2021-08-23 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(nsaia) 약물전구체 및 이들의 새로운 의약적 용도
WO2009037705A2 (en) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. Esters of n-phenylanthranilic acid for use in the treatment of cancer and inflammation
US8765815B2 (en) 2007-09-20 2014-07-01 Ramot At Tel-Aviv University Ltd. N-phenyl anthranilic acid derivatives and uses thereof
RU2630577C2 (ru) * 2008-12-04 2017-09-11 Чунси ЮЙ Композиции интенсивного проникновения и их применение
PL2427475T3 (pl) 2009-05-08 2021-07-19 Techfields Biochem Co., Ltd. Kompozycje proleku o wysokim przenikaniu peptydów i związków powiązanych z peptydami
US9969751B2 (en) 2009-06-10 2018-05-15 Techfields Pharma Co., Ltd. High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
US20120022116A1 (en) * 2010-07-20 2012-01-26 Huayun Deng Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
CN116898848A (zh) 2012-01-18 2023-10-20 苏州泰飞尔医药有限公司 治疗肺部疾病的高穿透力前药组合物和医药组合物
CN105143174B (zh) * 2013-03-15 2021-01-12 苏州泰飞尔医药有限公司 治疗帕金森疾病的新型高穿透力药物及其药物组合物
US9862698B2 (en) 2014-12-16 2018-01-09 Adt Pharmaceuticals, Inc. Indenyl compounds, pharmaceutical compositions, and medical uses thereof
US20160168108A1 (en) 2014-12-16 2016-06-16 Adt Pharmaceuticals, Inc. Method of treating or preventing ras-mediated diseases
JP7169008B2 (ja) 2018-04-26 2022-11-10 エーディーティー ファーマシューティカルズ,エルエルシー 抗がんインデン、インダン、アザインデン、アザインダン、医薬組成物および使用
WO2020070557A1 (en) * 2018-10-02 2020-04-09 Q Biomed Inc. Modified therapeutic agent analogs of mefenamic acid
WO2021042024A1 (en) * 2019-08-30 2021-03-04 University Of South Florida Sting modulators, compositions, and methods of use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB100208A (en) * 1915-03-24 1917-03-01 Isidore Swientoslawsk Morrison Improvements in Watch Movements.
US2671805A (en) * 1952-07-02 1954-03-09 Searle & Co Basically substituted o-arylamino-benzamides
GB984471A (en) * 1961-01-12 1965-02-24 Parke Davis & Co Anthranilic acid esters and methods for producing the same
BE630053A (pl) * 1962-03-27
US3420871A (en) * 1964-09-01 1969-01-07 Parke Davis & Co Anthranilic acid esters
DK121236B (da) * 1967-07-03 1971-09-27 Gea As Analogifremgangsmåde til fremstilling af terapeutisk aktive, basisk substituerede amider af N-substituerede antranilsyrer, eller syreadditionssalte deraf.
GB1187259A (en) * 1967-10-23 1970-04-08 Hexachimie New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture
US3814811A (en) * 1972-06-07 1974-06-04 Andreu Sa Dr Method of eliminating or alleviating local pain with diethylaminoethyl flufenamate
JPS57183738A (en) * 1981-05-06 1982-11-12 Yamanouchi Pharmaceut Co Ltd Aromatic carboxylic acid derivative
AU1508988A (en) * 1987-04-27 1988-10-27 Syntex Pharmaceuticals International Ltd. Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal antiinflammatory drugs
US5654337A (en) 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
AUPN531195A0 (en) 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
KR100213465B1 (ko) 1996-11-01 1999-08-02 최좌진 케토프로펜 패취 조성물
US5885597A (en) 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
MXPA00012844A (es) 1998-07-07 2004-05-21 Transdermal Technologies Inc Composiciones para la liberacion transdermica rapida y sin irritacion de agentes farmaceuticamente activos y metodos para formular tales composiciones y liberar los mismos.
US6416772B1 (en) 2001-01-12 2002-07-09 H. Wayne Van Engelen Topical dermal anaesthetic
US6528040B1 (en) 2001-01-18 2003-03-04 Maurine Pearson EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
US7052715B2 (en) 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof

Also Published As

Publication number Publication date
EP2623495A1 (en) 2013-08-07
EP2084132B1 (en) 2018-08-08
CN101506168B (zh) 2014-12-10
WO2008029199A1 (en) 2008-03-13
EP2084132A4 (en) 2010-05-26
CN101506168A (zh) 2009-08-12
ES2694685T3 (es) 2018-12-26
EP2084132A1 (en) 2009-08-05
HK1137426A1 (en) 2010-07-30
EP2623495B1 (en) 2019-05-01
ES2735287T3 (es) 2019-12-17
PL2623495T3 (pl) 2019-11-29

Similar Documents

Publication Publication Date Title
PL2084132T3 (pl) Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry
PL2061749T3 (pl) Dodatnio naładowane, rozpuszczalne w wodzie proleki acetaminofenu i związków pokrewnych o bardzo dużej szybkości przenikania przez skórę
EP2046727A4 (en) POSITIVELY LOADED, WATER-SOLUBLE PRODRUGS FROM DICLOFENAC WITH VERY FAST SKIN PENETRATION SPEED
EP2041068A4 (en) POSITIVE-LOADED, WATER-SOLUBLE PRODRUGS OF IBUPROFEN WITH A VERY FAST SKIN PENETRATION RATE
IL217370A (en) New nucleic acid matrices and methods for using them
PT2391620E (pt) Dicianopiridinas substituídas por alquilamina e seus profármacos de ésteres de aminoácidos
ZA201102120B (en) Improved method of rna display
IL209855A0 (en) Supression of neuroedocrine diseases
EP2125697A4 (en) POSITIVELY LOADED WATER-SOLUBLE PRODRUGS OF RETINOIDS AND RETINOIDARY COMPOUNDS WITH VERY HIGH SKIN PENETRATION RATES
PT2049482E (pt) Profármacos solúveis em água carregados positivamente de ácidos aril- e heteroarilacéticos com velocidade de penetração na pele muito rápida
IL209383A0 (en) Carbonate prodrugs and methods of using the same
IL218498A (en) Ketone-adapted opioid drug adjuvants, method of preparation, preparations containing them and their use
EP3206488A4 (en) Curcumin analogues as zinc chelators and their uses
PL2084124T3 (pl) Dodatnio naładowane rozpuszczalne w wodzie proleki prostaglandyn i związków pokrewnych o bardzo dużych szybkościach przenikania przez skórę
EP2570417A4 (en) THIENOPYRIDINE ESTER DERIVATIVE CONTAINING NITRILE, PREPARATION METHOD, USE AND COMPOSITION THEREOF
EP2084165A4 (en) PRO-DRUGS OF WATER-SOLUBLE OXICAMS POSITIVE AND RELATED COMPOUNDS WITH VERY HIGH SKIN PENETRATION SPEED
EP2069485A4 (en) PREPARATION OF NEGATIVE STRAND RNA VIRUSES BY ELECTROPORATION
GB201118517D0 (en) Article formed using nanostructured ferritic alloy
SI2189442T1 (sl) Postopek in intermediati za pripravo aliskirena
IL223180A0 (en) Agomelatine intermediates and preparation method thereof
ZA200807674B (en) Prodrugs of benzoquinolizine-2-carboxylic acid
ZA200908631B (en) N-Oxides of venlafaxine and O-Desmethylvenlafaxine as prodrugs
EP2077991A4 (en) POSITIVELY LOADED, WATER-SOLUBLE PRODRUGS OF LOTS AND RELATED COMPOUNDS WITH VERY HIGH SKIN PENETRATION RATES
PT2493842T (pt) Derivados de crisantemilo como atratores de cochonilha
GB0912493D0 (en) Preparation of bile acids and intermediates thereof